novo nordisk lawsuit semaglutide accuses Lilly of running 'false and misleading' GLP-1 ads Novo Nordisk sues Hims for

Using it too often

In a 2-year trial involving patients with type 2 diabetes mellitus (T2DM) and high cardiovascular risk, more events of diabetic retinopathy complications occurred in the patients treated with semaglutide injection (3%) compared to placebo (1.8%)

Baseline characteristics of the diabetic subgroup painted a picture of meaningful metabolic dysfunction

Months 4+ (potentially protective): Weight loss is progressing, which reduces bladder pressure and improves urinary function

The delayed gastric emptying primarily affects how quickly drugs are absorbed rather than the total amount absorbed, which may explain why clinically significant interactions are less common than initially feared

Her aesthetic ages gracefully, making it aspirational for a wide audience